These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2165223)

  • 1. [Use in hemodialysis and hemofiltration of CY 216 (Fraxiparine) administered via intravenous bolus in patients with acute and chronic renal insufficiency with and without hemorrhagic risk].
    Steinbach G; Bosc C; Caraman PL; Azoulay E; Olry L; D'Azemar P; Chopin J
    Nephrologie; 1990; 11(1):17-21. PubMed ID: 2165223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anticoagulation in hemodialysis sessions with a low molecular weight heparin (CY 222, Choay). Dosage studies in chronic hemodialysis. Its use in patients at high risk of hemorrhage].
    Dieval J; Morinière P; Roussel B; Bayrou B; Fournier A; Delobel J
    J Mal Vasc; 1987; 12 Suppl B():114-8. PubMed ID: 2834482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of the low-molecular heparin, Fraxiparine, during hemodialysis].
    Monhart V; Petrů K
    Cas Lek Cesk; 1998 Jan; 137(1):18-21. PubMed ID: 9511272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevention of thrombogenesis in the extracorporeal circuit of hemodialysis with a low molecular heparin: standardization of the dosage with a better hemorrhagic risk/effectiveness ratio].
    Barata JD; Oliveira C; Bruges M; Gusmão L; Santana A; Ponce P; Simões J; Freire I; Crespo F; da Silva AN
    Acta Med Port; 1992 Feb; 5(2):65-70. PubMed ID: 1317657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of acute pulmonary embolism with a low molecular weight heparin by the intravenous route. Study of the optimal dosage].
    Quilliet L; Charbonnier B; Delahousse B; Gruel Y; Brochier ML; Leroy J; Toulemonde F
    Arch Mal Coeur Vaiss; 1988 Oct; 81(10):1219-25. PubMed ID: 2851965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The use of enoxaparine for anticoagulation in extracorporeal circulation in hemodialysis at high risk for hemorrhage].
    Dechelette E; Pouzol P; Jurkovitz C; Kuentz F; Polack B; Cuzin E; Woler M
    J Mal Vasc; 1987; 12 Suppl B():105-7. PubMed ID: 2834479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low molecular weight heparin (CY-216) versus unfractionated heparin in chronic hemodialysis.
    Grau E; Sigüenza F; Maduell F; Linares M; Olaso MA; Martinez R; Caridad A
    Nephron; 1992; 62(1):13-7. PubMed ID: 1331831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulant-free Genius haemodialysis using low molecular weight heparin-coated circuits.
    Frank RD; Müller U; Lanzmich R; Groeger C; Floege J
    Nephrol Dial Transplant; 2006 Apr; 21(4):1013-8. PubMed ID: 16326745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring of heparins in haemodialysis using an anti-factor-Xa-specific whole-blood clotting assay.
    Harenberg J; Haaf B; Dempfle CE; Stehle G; Heene DL
    Nephrol Dial Transplant; 1995; 10(2):217-22. PubMed ID: 7753456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical evaluation of low-dose heparin in haemodialysis: a prospective study using the heparin-coated AN69 ST membrane.
    Chanard J; Lavaud S; Maheut H; Kazes I; Vitry F; Rieu P
    Nephrol Dial Transplant; 2008 Jun; 23(6):2003-9. PubMed ID: 18156457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low molecular weight heparin and haemodialysis: neutralization by protaminchloride.
    Andrassy K
    Blood Coagul Fibrinolysis; 1993 Dec; 4 Suppl 1():S39-43. PubMed ID: 8180328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low molecular weight heparin in haemodialysis for chronic renal failure: dose finding study of CY222.
    Ireland H; Lane DA; Flynn A; Pegrum AC; Curtis JR
    Thromb Haemost; 1988 Apr; 59(2):240-7. PubMed ID: 2838924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracorporeal management of acute renal failure patients at high risk of bleeding.
    Ward DM; Mehta RL
    Kidney Int Suppl; 1993 Jun; 41():S237-44. PubMed ID: 8320930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Parameters of hemostasis during treatments associating fractionated heparin administered subcutaneously to standard and fractionated heparin administered intravenously in the chronic hemodialysis patient].
    Morinière P; Diéval J; Roussel B; Gross S; Bayrou B; Delobel J; Fournier A
    Nephrologie; 1990; 11(3):141-6. PubMed ID: 2234270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal anticoagulation strategy in haemodialysis with heparin-coated polyacrylonitrile membrane.
    Lavaud S; Canivet E; Wuillai A; Maheut H; Randoux C; Bonnet JM; Renaux JL; Chanard J
    Nephrol Dial Transplant; 2003 Oct; 18(10):2097-104. PubMed ID: 13679486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of a low molecular weight heparin, CY 222, in the treatment of consumption coagulopathy].
    Audibert G; Lambert H; Toulemonde F; Alexandre P; Laprevote-Heully MC; Bollaert PE; Bauer P; Larcan A
    J Mal Vasc; 1987; 12 Suppl B():147-51. PubMed ID: 2834489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-molecular-weight heparin Fraxiparin in chronic hemodialysis. A dose-finding study.
    Morinière P; Dieval J; Bayrou B; Roussel B; Renaud H; Fournier A; Delobel J
    Blood Purif; 1989; 7(6):301-8. PubMed ID: 2558691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A low molecular weight heparin ("fragmin") for routine hemodialysis: a crossover trial comparing three dose regimens with a standard regimen of commercial unfractionated heparin.
    Anastassiades E; Lane DA; Ireland H; Flynn A; Curtis JR
    Clin Nephrol; 1989 Dec; 32(6):290-6. PubMed ID: 2558829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Equivalent effective doses of heparin and low molecular weight heparin(oid)s in haemodialysis for chronic renal failure.
    Lane DA; Ireland H; Tew CJ; Flynn A; Curtis JR
    Acta Chir Scand Suppl; 1988; 543():101-4. PubMed ID: 2847457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous hemofiltration with a low molecular weight heparin, enoxaparine: report on two cases.
    Lorenzini JL; Freysz M; Honnart D; Zeller V; Dutrillaux F
    Int J Clin Pharmacol Ther Toxicol; 1991 Mar; 29(3):89-91. PubMed ID: 1649141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.